Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Revolution Medicines Inc
(NQ:
RVMD
)
34.53
-1.30 (-3.63%)
Streaming Delayed Price
Updated: 2:31 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
680,800
Open
36.01
Bid (Size)
34.51 (2)
Ask (Size)
34.55 (1)
Prev. Close
35.83
Today's Range
34.23 - 36.37
52wk Range
15.44 - 38.73
Shares Outstanding
106,313,250
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Top 3 Health Care Stocks That May Collapse In Q2
April 12, 2024
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 10, 2024
Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share.
Via
Benzinga
Performance
YTD
+22.32%
+22.32%
1 Month
+12.11%
+12.11%
3 Month
+30.01%
+30.01%
6 Month
+19.07%
+19.07%
1 Year
+37.13%
+37.13%
More News
Read More
What's Going On With Revolution Medicines Stock?
April 10, 2024
Via
Benzinga
Revolution Medicines Inc. (NASDAQ: RVMD) Climbs to New 52-Week High
April 10, 2024
Via
Investor Brand Network
Revolution Medicines's Earnings: A Preview
February 23, 2024
Via
Benzinga
What 6 Analyst Ratings Have To Say About Revolution Medicines
November 07, 2023
Via
Benzinga
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
April 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Morgan Stanley Maintains Equal-Weight Rating for Revolution Medicines: Here's What You Need To Know
March 08, 2024
Via
Benzinga
Earnings Scheduled For February 26, 2024
February 26, 2024
Via
Benzinga
Uncovering Noteworthy Technical Analysis Findings for REVOLUTION MEDICINES INC (NASDAQ:RVMD).
February 01, 2024
Via
Chartmill
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
December 15, 2023
Via
InvestorPlace
3 Biotech Stocks That Could Boom or Bust by 2025
November 16, 2023
Via
InvestorPlace
Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details
November 16, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Via
Benzinga
Preview: Revolution Medicines's Earnings
November 03, 2023
Via
Benzinga
Crude Oil Falls Sharply; Apollomics Shares Plunge
October 23, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Revolution Medicines Stock Is Crashing Today
October 23, 2023
Via
The Motley Fool
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 23, 2023
Via
Benzinga
Nasdaq Turns Higher; Akumin Shares Jump
October 23, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday
October 23, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Revolution Medicines Crashes 39% On Lackluster Test Results In Cancer Treatment
October 23, 2023
Via
Investor's Business Daily
Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September
October 23, 2023
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 23, 2023
Via
Benzinga
Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90
October 16, 2023
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.